# FDA Inspection 1012236 - Regenerative Biologics, Inc. - May 16, 2017

Source: https://www.keypedia.com/records/fda_inspections/regenerative-biologics-inc/97d5a33e-53e9-4700-87f1-7ff1f49829af
Source feed: FDA_Inspections

> FDA Inspection 1012236 for Regenerative Biologics, Inc. on May 16, 2017. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1012236
- Company Name: Regenerative Biologics, Inc.
- Inspection Date: 2017-05-16
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 798307 - 2012-09-07](https://www.keypedia.com/records/fda_inspections/regenerative-biologics-inc/f09550d2-0684-497b-8d2c-124cb7bca3cb)
- [FDA Inspection 675587 - 2010-08-11](https://www.keypedia.com/records/fda_inspections/regenerative-biologics-inc/84bc7477-5cb8-4eee-ada3-5001e64d36a8)

Company: https://www.keypedia.com/companies/regenerative-biologics-inc/89043dd0-2a59-41ae-acfa-d1eb822442b6

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d